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Abstract
Study Design: Systematic review.
Objectives: Cyanoacrylate glue closure has been utilized for dermal closure in surgical incisions. Its safety and efficacy in spine
surgery are not established. The authors perform a systematic review to determine the rate of surgical site infection (SSI), wound
dehiscence, and wound erythema with cyanoacrylate dermal closure in spine surgery.
Methods: A systematic review adhering to PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses)
guidelines was performed utilizing the PubMed/MEDLINE, EMBASE, and Cochrane databases on patients undergoing spine
surgery with cyanoacrylate dermal closure. Pooled analysis was performed with stratification of patients according to spinal level
and the presence/absence of instrumentation. Risk-of-bias and methodological quality was appraised using 17 prespecified criteria.
Results: Five articles (1 retrospective cohort study, 4 cases series) with a total of 1282 patients were included. A total of 967
patients, all diagnosed with degenerative spine disease, were suitable for pooled analysis. In 290 patients who underwent anterior
cervical discectomy and fusion, and in 23 patients with posterior cervical decompression (without instrumentation), there was 0%
rate of SSI, wound dehiscence, and erythema. In 489 patients who underwent lumbar microdiscectomy, there was 0.41% rate of
SSI, 0.20% rate of wound dehiscence, and 0.20% rate of wound erythema. In 165 lumbar laminectomy patients, there was a 1.82%
rate of SSI, 0.61% rate of wound dehiscence, and 0% rate of wound erythema.
Conclusion: Cyanoacrylate dermal closure for the aforementioned procedures is associated with low rates of wound com-
plications (SSI, dehiscence, and erythema). Further studies should be performed, especially in nondegenerative surgery, instru-
mented thoracic and lumbar spine surgery.
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Introduction
Cyanoacrylates were first synthesized in the 1940s as part of
industrial research during World War II. N-butyl cyanoacry-
late, and 2-octyl cyanoacrylate are the most commonly forms
used in current surgical practice for incisional wound closure.
Reported advantages of cyanoacrylate use include the ease of
application,1 decreased time taken for wound closure, potential
cost savings,2 and a reduced incidence of surgical site infection
(SSI).3
The use of cyanoacrylates has been studied extensively in
the field of surgery.4 However, its safety and efficacy in spine
surgery is less established. Incisions employed in spine surgery
are often in mobile body regions (eg, posterior cervical wounds
with neck flexion) and risk of wound dehiscence is an under-
standable concern when cyanoacrylates are used. Furthermore,
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while cyanoacrylates have been reported to reduce SSI in non-
spinal surgery,5 its ability to reduce infections in spine surgery
is unclear.
Thus, the authors conduct a systematic review and pooled
analysis to determine the incidence of wound complications,
namely SSI, wound dehiscence and wound discharge when
cyanoacrylates are used for dermal closure in spine surgery.
Risk of bias is systematically assessed in a structured manner
according to 17 prespecified criteria.
Methods
This systematic review was conducted in accordance to the
Preferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) guidelines.6
Eligibility Criteria
All studies utilizing cyanoacrylates for dermal closure in spine
surgery and which included at least one of the following out-
come measures were included: incidence of SSI, incidence of
wound dehiscence, and incidence of wound erythema/inflam-
mation. To be included, dermal closure has to be achieved
solely by use of cyanoacrylates, and not as an adjunct to stan-
dard dermal/subcuticular suture closure. Diagnosis of SSI was
defined in accordance to the Centers for Disease Control and
Prevention (CDC) SSI criteria.
Information Sources
The MEDLINE/PubMed, Web of Science, EMBASE, and
Cochrane databases were searched from date of inception to
January 2, 2019. Boolean combinations of the following terms,
used as either MeSH (PubMed) terms or keywords were used in
the search strategy: “wound closure techniques,” “spine
surgery,” “postoperative period,” “risk factors,” “surgical
wound infection,” and “cyanoacrylate.”
Study Selection and Data Extraction
Two authors (TT, JT) screened all articles independently for
study inclusion, with contested citations absolved by consen-
sus. Database searches were supplemented by manual searches
of the bibliographies and citations of included studies to iden-
tify further suitable articles.
Data from included studies was extracted onto a prefor-
matted data collection form on Microsoft Excel (Redmond,
WA). Extracted data included study design, level of evidence,
number of subjects, incidence of SSI, incidence of wound
dehiscence, incidence of wound erythema/inflammation, spinal
level of operation and type of surgery.
Assessment of Reporting Quality
Risk of bias of included studies was assessed. A prespecified
set of 17 items pertinent to the methodological rigor of the
included studies, as adapted from the CONSORT7 and
STROBE8 guidelines were recorded. These items include study
design, study setting, time frame of study, method of case
identification, sample size calculation, indication for surgery,
type of surgical procedure, definition of SSI, blinding, duration
of follow-up, and statistical analysis with regard to univariate
and multivariate analysis (see Table 1 for full criteria).
Table 1. Risk of Bias Criterion Analysis.
First Author, Year
Ando, 2014 Wachter, 2010 Tacconi, 2018 Yang, 2009 Hall, 2005
Study design Cohort Case series Case series Case series Case series
Study setting recorded     þ
Time period of study stated þ  þ þ þ
Eligibility criteria stated þ þ þ þ þ
Method of case identification þ þ þ þ þ
Sample Size calculation     
Indication for surgery recorded þ - þ þ þ
Type of surgical procedure recorded þ þ þ þ þ
Spinal level recorded þ þ þ þ þ
Use of intravenous antibiotics for SSI prophylaxis þ þ   
Definition for SSI stated þ    
SSI outcome assessors blinded     
Duration of follow-up more than 30 days þ þ þ  þ
Type of dressing used stated þ þ   þ
Duration of dressings left intact stated þ þ   þ
Known risk factors for SSI recorded þ þ  þ 
Univariate analysis undertaken þ    
Multivariate analysis undertaken     
Abbreviation: SSI, surgical site infection.
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Analysis of Data
As the key purpose of this review is to determine incidence of
wound complications with cyanoacrylates, no comparative sta-
tistics was used. Results from included comparative studies are
qualitatively analyzed. A pooled analysis of suitable available
data from all included studies was performed. Outcome mea-
sures are calculated from pooled analysis and were stratified in
accordance to spinal level of surgery (cervical, thoracic, lum-
bosacral) and type of procedure (including the presence/
absence of instrumentation).
Results
A total of 10770 citations were derived from the electronic
search strategy. After screening of titles and abstracts, 101
remaining potential articles underwent full-text screening. In
all, 97 articles were excluded after full text screening. The
study by Howard et al9 was excluded as patients with
cyanoacrylate wound closure also simultaneously underwent
skin closure with subcuticular monocryl suture. A citation and
bibliographic search of the remaining articles resulted in one
additional article for inclusion.10 As such, a total of 5 arti-
cles2,10-13 were included in this review (Figure 1).
Study Characteristics
Of the 5 articles, 1 was a retrospective cohort study,2 and the
remaining 4 studies10-13 were surgical case series. The number
of subjects in the included studies ranged from 57 to 609
(median: 308). Four studies used 2-octyl-cyanoacrylate,
and 1 study10 used butyl-cyanoacrylate for dermal closure. All
5 studies were conducted at teaching university hospitals. Two
studies2,11 reported no conflicts of interest or industry sponsor-
ship, while the remaining studies10,12,13 did not report on con-
flicts of interest.
In the only retrospective cohort study by Ando et al,2 a total
of 609 consecutive patients undergoing spinal surgery were
Records identified through 
database searching 
(n = 10,770)
Sc
re
en
in
g
In
cl
ud
ed
El
ig
ib
ili
ty
noitacifitnedI
Additional records identified 
through other sources 
(n = 0)
Records after duplicates removed 
(n = 9598)
Records screened 
(n = 9598)
Records excluded 
(n = 9497)
Full-text articles assessed 
for eligibility 
(n = 101)
Full-text articles excluded
(n = 97)
Studies included in 
qualitative synthesis 
(n = 4) Studies included post 
bibliographic and citation review 
(n =1)
Total studies included
(n=5)
Figure 1. PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flow diagram of study inclusion.
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included. A total of 315 patients underwent 2-octyl cyanoacry-
late dermal closure, compared with 294 patients who under-
went staple closure. Subdermal wound closure between the 2
groups were similar; that is, 2-0 absorbable suture closure of
subdermal layer. Staples were removed 10 to 14 days after the
operation and postsurgical dressings were left intact for 7 to
10 days after surgery. SSI was the primary outcome in this
study, with none of the 2-octyl-cyanoacrylate patients, and 8
(2.72%) of the patients with skin staples developing a SSI
(P < .01). There were no cases of wound dehiscence or wound
inflammation/erythema in the cyanoacrylate group. Further-
more, the average time taken to close a 10-cm wound was
shorter when cyanoacrylate was used rather than staples
(19.9 + 10.7 vs 48.0 + 12.6 seconds, respectively,
P < .001). This study included patients who underwent surgery
at all spinal levels, mainly for degenerative conditions (>90%
of patients). Overall, 30% of patients in each group underwent
instrumented spinal fusion. Unfortunately, the presented data
in this study, while suitable for calculation of overall wound
complication rates, is not amenable to subgroup analysis in
accordance to level and type of spinal surgery.
Data Pooling and Subgroup Analysis (Table 2)
A total of 1282 underwent cyanoacrylate dermal closure. The
overall rate of SSI in the five included studies is 0.39% (5 of
1282 patients). This included 2 superficial SSI and 1 deep SSI
(type of SSI not recorded in remaining 2 cases). The overall
rate of wound dehiscence is 0.16% (2 of 1282 patients), and
that of wound erythema/inflammation is 0.08% (1 of 1282
patients).
Data from 4 of the 5 studies (Ando et al2 excluded due to
lack of subgroup analysis) totaling 967 patients was pooled for
further analysis. Coincidentally, it should be noted that all
patients included in this subgroup analysis were operated on
for degenerative spine conditions. In the cervical spine, a total
of 290 patients underwent anterior cervical discectomy and
fusion (ACDF), and 23 patients underwent posterior cervical
decompression (without instrumentation). In these 2 patient
subgroups, there was a 0% rate of SSI, wound dehiscence, and
wound erythema.
In the lumbosacral spine, a total of 489 patients underwent
lumbar microdiscectomy. 0.41% (2 of 489) of patients devel-
oped an SSI. The incidences of wound dehiscence and wound
erythema are 0.20% (1 of 489 patients) and 0.20% (1 of 489
patients), respectively. A total of 165 patients underwent lum-
bar laminectomy, with an SSI rate of 1.82% (3 of 165 patients),
wound dehiscence rate of 0.61% (1 of 165 patients), and no
patients with wound erythema/inflammation.
From the 4 included studies in the subgroup analysis, there
were no patients who underwent thoracic spine surgery or pos-
terior lumbosacral fusion surgery. As such, it is not possible to
determine the wound complication rates for these procedures.
Risk of Bias and Methodological Assessment (Table 1)
Reporting of the 17 criteria pertinent to methodological quality
and risk of bias of the included studies was assessed, as sum-
marized in Table 1. In general, the study by Ando et al2 satis-
fied most of the criteria, reporting on 13 of 17 (76.5%) of the
criteria. Hall et al13 reported on 10 of 17 (58.8%) and Wachter
et al11 reported on 9 of 17 (52.9%) of the criteria. The remain-
ing two studies reported on less than half of the stipulated
criteria (7 of 17; 41.2%). All the studies utilized consecutive
patients as their method of case identification. Sample size
calculation was not performed for all studies, a factor mitigated
by the fact that 4 of the 5 included studies are case studies. The
general type of surgical procedure was recorded in all studies.
Use of perioperative antibiotics, a major measure to reduce
postoperative SSI, was only recorded in 2 of 5 studies2,11
(40%). Similarly, an attempt to record patient and clinical vari-
ables known to influence wound outcomes was recorded in 3 of
5 studies2,11,12 (60%).
Discussion
Results from this systematic review demonstrate that cyanoa-
crylate dermal closure for anterior cervical discectomy and
fusion, lumbar microdiscectomy, and lumbar laminectomy is
Table 2. Pooled Analysis in Accordance to Spinal Level and Procedure Type.
Pooled N No. of SSI (%) No. of Dehiscence (%) No. of Wound Erythema (%)
Cervical
ACDF 290 0 0 0
Posterior, noninstrumented 23 0 0 0
Posterior, instrumented 0 NA NA NA
Thoracic
Posterior, noninstrumented 0 NA NA NA
Posterior, instrumented 0 NA NA NA
Lumbosacral
Microdiscectomy 489 2 (0.41) 1 (0.20) 1 (0.20)
Lumbar laminectomy 165 3 (1.8) 1 (0.61) 0
Posterior, instrumented 0 NA NA NA
Abbreviations: ACDF, anterior cervical discectomy and fusion; NA, not applicable.
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associated with a low rate of SSI and wound dehiscence as
demonstrated in a relatively large number of patients. There
was a 0% rate of SSI in patients who underwent posterior
cervical decompression (without fusion), although the number
of included patients is small (23 patients).
The rate of SSI for cyanoacrylate dermal closure compares
favorably to that in the contemporary literature for the proce-
dures described (Table 2). Cyanoacrylates have not only been
found to provide a mechanical barrier against bacterial infec-
tion,14 they have also been found to possess bactericidal prop-
erties against Gram-positive bacteria.14 Given the potentially
devastating consequences of SSI in spine surgery, any measure
that can reduce SSI should be rigorously studied and imple-
mented as appropriate. A Cochrane review of randomized
trials4 investigating the use of tissue adhesives in all surgical
incisions demonstrated no difference in rate of SSI when com-
pared to suture closure. However, none of the trials included in
this Cochrane review included spinal surgery patients.
While the rate of SSI with cyanoacrylate dermal closure in
noninstrumented lumbar surgery is low, there exists no data in
the current literature with regard to instrumented thoracic and
lumbar instrumented surgery. Wound complications, especially
in the form of SSI and wound dehiscence, are major concerns in
long-segment thoracolumbar instrumented spine surgery,
where incisions are longer and surgical invasiveness increased
compared with noninstrumented surgery. A recent systematic
review of adult spinal deformity surgery reported a periopera-
tive SSI rate (requiring surgical debridement) of 2.24% and
wound dehiscence rate (requiring surgical closure) of
0.25%.15 Given the paucity of evidence, the authors are unable
to comment on the impact of cyanoacrylate dermal closure in
instrumented thoracic and lumbar spine surgery.
The risk of wound dehiscence remains a concern for cya-
noacrylate dermal closure. Shapiro et al,16 in an ex vivo porcine
study, found no significant difference in wound tensile strength
when 2-octyl cyanoacrylate was compared with 4-0 poligleca-
prone subcuticular sutures. However, in the aforementioned
Cochrane review,4 there was a lower risk of wound dehiscence
with suture closure when compared with tissue adhesive. While
the rate of wound dehiscence in the present review is remark-
ably low, spinal surgeons should be cognizant of the potential
risk of wound dehiscence when using cyanoacrylate for dermal
closure.
Limitations
The limitations of this systematic review stems primarily from
the quality of the included articles. Four of the 5 articles
included are surgical case series, which have traditionally been
of variable quality. Indeed, a structured methodological and
risk of bias assessment reveals the reporting deficiencies of
each included study (Table 1). The study by Ando et al2 is the
only (retrospective) cohort study included in this review. While
it reports on the highest number (13 of 17) of risk of bias
criteria, deficiencies still exist in this study. For example,
this study included patients with a myriad of underlying
pathologies (degenerative, spine trauma, spine tumor) which
confounds analysis of wound outcomes.
The pooled analysis in this review included patients who
underwent surgery for degenerative conditions only. As such,
the safety of cyanoacrylate dermal closure for nondegenerative
pathologies (eg, spine trauma, spine tumors) cannot be verified.
Further studies should be performed in this area, as wound
complications, including infection, dehiscence, and cerebrosp-
inal fluid leak are potentially increased in these pathologies.
Furthermore, due to inadequacy of data in the included studies,
results from this review do not take into account confounding
variables that can have an impact on wound outcomes.
Conclusion
Cyanoacrylate dermal closure for ACDF, posterior cervical
decompression, lumbar microdiscectomy, and lumbar lami-
nectomy is associated with low rates of wound complications
(SSI, dehiscence, and erythema). Further studies should be
performed in nondegenerative spine surgery, instrumented
thoracic, and lumbar surgery. High-quality comparative studies
in the form of randomized controlled trials should be under-
taken to compare relative efficacy of cyanoacrylate versus
other wound closure methods with regard to wound outcomes.
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